[January 10, 2013] |
|
PerkinElmer Introduces Novel Life Sciences Solutions at the Society for Laboratory Automation and Screening (SLAS) 2013 Conference
ORLANDO, Fla. --(Business Wire)--
PerkinElmer,
Inc., a global leader focused on improving the health and safety of
people and the environment, will showcase an array of novel products at
the 2nd
Annual Society for Laboratory Automation and Screening (SLAS)
Conference (#SLAS2013)
in Orlando, January 12-16, including an Epigenetic
Biochemical Toolbox, the JANUS®
NGS Express™ liquid handling workstation and the Sciclone®
NGSx Workstation™ platform (booth #1207).
The PerkinElmer JANUS(R) NGS Express(TM) liquid handling workstation automates key procedures involved in the sample preparation workflow for benchtop next-generation DNA sequencing platforms. (Photo: Business Wire)
"We are excited to participate in this significant industry event and
bolster our commitment to our customers with new and transformational
innovations that will help them to advance the prevention, detection and
treatment of disease," said Kein Hrusovsky, president, Life Sciences
and Technology, PerkinElmer. "The study of epigenetics and the exciting
innovations in next generation sequencing are proving to be powerful
tools for better understanding cancer and other debilitating diseases so
that we are better equipped to combat them. We believe our
transformative assays and instrumentation will help enable our customers
to bring better, more effective medicines to market."
PerkinElmer products on display at SLAS 2013 include:
-
An expanded Epigenetic
Biochemical Toolbox with more than 40 validated enzymatic assays
for the detection of post-translational modifications of histones H3,
H4 and p53. The PerkinElmer assays cover all the major writer and
eraser enzyme families and can be used across a range of substrates,
from peptides to histones to full nucleosomes. The toolbox complements
the novel AlphaLISA®
Epigenetic Cellular Detection Kits for cell-based detection of
epigenetic modifications. Together, these products allow interrogation
of compounds in more biologically relevant formats and improve
efficiency in the identification of drug candidates targeting
epigenetic enzymes related to key disease states.
PerkinElmer's
epigenetic portfolio provides researchers access to fully validated
reagents and assay development services that offer valuable time
savings in the race to discover novel drug candidates. These highly
specific reagents along with PerkinElmer's knowledgeable support for
the development of epigenetic assays help researchers identify and
characterize their lead compounds more quickly and efficiently.
-
The PerkinElmer JANUS®
NGS Express™ liquid handling workstation automates key procedures
involved in the sample preparation workflow for benchtop
next-generation DNA sequencing platforms. Validated methods include
fragment library preparation, amplicon sequencing, normalization and
complex sample pooling for multiplexed sequencing experiments. The
JANUS NGS Express enables better sample-to-sample consistency and
decreased hands-on time with the capability of efficient sample
preparation of up to 24 libraries for higher quality library prep with
increased yields and fewer errors.
-
The PerkinElmer Sciclone®
NGSx Workstation™ platform for high-throughput next generation
sequencing workflows helps researchers accelerate the preparation of
DNA samples for sequencing with minimal user intervention. The
Sciclone NGSx, allows for full walk-away library prep for up to 96
samples per run with standardized protocols available for exome
capture, RNA-Seq and fragment library prep using kits from multiple
suppliers. Automated sample prep with the Sciclone NGSx helps provide
consistency, repeatability and traceability, eliminate
cross-contamination and has the flexibility for future application
development enabling consistency, robustness and the ability to
utilize the chemistry of your choice.
-
PerkinElmer offers a full
sequencing portfolio dedicated to helping meet scientific
challenges including sample isolation, fragment and sizing, library
generation, sample quantification, sequencing and analysis.
The above products are for research use only and not for use in
diagnostic procedures.
About PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader focused on improving the health and
safety of people and the environment. The company reported revenue of
approximately $1.9 billion in 2011, has about 7,400 employees serving
customers in more than 150 countries, and is a component of the S&P 500
Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20130110006299/en/
[ Back To TMCnet.com's Homepage ]
|